MedTrace Logo

Nociception Level-guided Remifentanil Dosing in Children During General Anesthesia

NCT05725382 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 264

Last updated 2023-08-24

No results posted yet for this study

Summary

The investigators aim to investigate whether administration of a short-acting opioid (remifentanil) guided by a pain monitor (nociceptive level monitor) during anesthesia, can reduce pain in children after surgery.

The investigators hypothesize that pain monitor-guided administration of remifentanil can reduce pain postoperatively compared with standard care.

Conditions

  • Surgical Procedure, Unspecified

Interventions

DEVICE

The NOL monitor (Pain Monitoring Device monitor-PMD200™)

NOL-guided perioperative remifentanil administration

Sponsors & Collaborators

  • Pia Jaeger, MD, PhD

    lead OTHER

Principal Investigators

  • Pia Jæger, MD, PhD · Department of Anaesthesia, The Juliane Marie Center, Rigshospitalet

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2025-10-30
Completion
2025-11-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05725382 on ClinicalTrials.gov